4-CHLOROMETHYL-3-(2,6-DICHLOROPHENYL)-5-METHYLISOXAZOLE, 95.0%, 1g

Benzyl3-(cyanomethylene)azetidine-1-carboxylate, 98%, 10g

Bis(4-tert-butylphenyl)phosphine oxide, 97%, 100mg

(3-Methyl-5-(trifluoromethyl)phenyl)boronic acid, 95.0%, 250mg

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 100mg

2-(Isopropylamino)acetonitrile hydrochloride, 95+%, 250mg

Isobutyric acid, >=99%, for synthesis, 25 l, PE/steel

8-Fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid, 97.0%, 100mg

3-Bromo-4-ethylbenzoic acid, 95.0%, 1g

3-Hydroxy-1-naphthoic acid, 97%, 250mg

Ethyl 2-(3,5-dichlorophenyl)acetate, 95.0%, 1g

3-Bromotoluene>98.0%(GC)25g

Screw vials conical, 1.5 ml, 1000 Piece(s)